Taken together, although tPA is the only approved treatment for acute ischemic stroke, cell-based therapy, especially BMSCs-based therapy, has also been shown to enhance function recovery, ameliorate cognitive dysfunction, and improve neuroplasticity after stroke. This evidence concerns the gene PLAT and Stroke.